Kannalife
Manufacturing · Pennsylvania, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
3805 Old Easton Rd, Doylestown, Pennsylv...Phone Number
(215) 695-6559Website
www.kannalife.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Kannalife
Kannalife Sciences, a subsidiary of Neuropathix, Inc., is a biopharmaceutical company dedicated to the research and development of innovative therapeutics targeting inflammation and neurodegenerative diseases. The company focuses on creating cannabinoid-based treatments for patients with significant unmet medical needs, including conditions like chemotherapy-induced peripheral neuropathy and chronic pain. Kannalife has developed a proprietary platform of CBD-like molecules that are significantly more potent and effective than traditional CBD. Their approach is science-based and data-driven, aiming to improve the pharmacokinetic and pharmacodynamic properties of cannabinoid therapeutics.Explore more
Kannalife Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Kannalife your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Kannalife had a recent Job posting/layoffs
Earning: See what the market has to say on Kannalife recently announced quarterly report
Check if Kannalife has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Kannalife
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Kannalife has new funding data
Product Launch: Get notified when Kannalife launches new products
Kannalife, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Kannalife is spiking on competitors!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to Kannalife
Compare insights from companies similar to Kannalife, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
<$5M
1-10
Private
-
2011
Mark KlevenSenior Vice President, Scientific Operations, Chief Operating Officer
Company Profile Activity
Activity Insights
Kannalife is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Kannalife is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Kannalife.
Kannalife financials insights
Gather financial insights about Kannalife, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2024
Grant
$1.5M
Kannalife Tech Stack
A closer look at the technologies used by Kannalife
See more technologies
Kannalife News & Media
Neuropathix, Inc. Reveals Visual Identity to Coincide With Its Mission for Socially Responsible Pain Management
DOYLESTOWN, Pa., Nov. 12, 2020 (GLOBE NEWSWIRE) -- Neuropathix, Inc. ("Neuropathix" or the “Company”) (OTCQB: NPTX), formerly Kannalife, Inc., is a socially responsible pain management life sciences company. For the past ten years, Neuropathix has discovered, developed and patented a global intellectual property estate of novel new monotherapeutic agents designed to prevent and reverse neuropathic pain, reduce oxidative stress, and act as anti-inflammatory neuroprotectants.Kannalife, Inc. Rebrands as Neuropathix, Inc. and Unveils New Ticker Symbol
DOYLESTOWN, Pa., Nov. 06, 2020 (GLOBE NEWSWIRE) -- Kannalife, Inc. (“Kannalife” or the “Company”) (OTCQB: KLFE), a biopharmaceutical and medchem company specializing in the research and development of potent novel monotherapeutics, announced today that the Company has changed its official name to Neuropathix, Inc. (“Neuropathix”) with a new ticker symbol (OTCQB: NPTX). “As the Company looks to expand on our biopharmaceutical research, the name Neuropathix better showcases our commitment to succeKannalife, Inc. Adds to Its Global IP Estate Receiving Patent Grant from Canada for Its Novel Anti-Inflammatory Compounds
DOYLESTOWN, Pa., Oct. 06, 2020 (GLOBE NEWSWIRE) -- Kannalife, Inc. (“Kannalife” or the “Company”) (OTCQB: KLFE), a biopharmaceutical and medchem company specializing in the research and development of potent novel monotherapeutics, announced today that the Company has been issued Canadian Patent CA2936506A1 specific to its patent known as WO2015/106108A2 titled, “Novel Functionalized 1,3-Benzene Diols and their Method of Use for the Treatment of Hepatic Encephalopathy” (the “PCT Patent”).Kannalife, Inc. Appoints Dr. Tage Honoré as Chairman of the Company’s Board of Advisors
DOYLESTOWN, Pa., Sept. 17, 2020 (GLOBE NEWSWIRE) -- Kannalife, Inc. (“Kannalife” or the “Company”) (OTCQB: KLFE), a biopharmaceutical medicinal chemistry company specializing in the research and development of potent novel monotherapeutics, announced today that it has appointed pharmaceutical and biotechnology industry veteran Dr. Tage Honoré as the Chairman of the Company’s Board of Advisors.
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Kannalife
Sign Up For FreeTo access detailed company insights
Kannalife Sciences, a subsidiary of Neuropathix, Inc., is a biopharmaceutical company dedicated to the research and development of innovative therapeutics targeting inflammation and neurodegenerative diseases. The company focuses on creating cannabinoid-based treatments for patients with significant unmet medical needs, including conditions like ch... Read More
